Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.
about
The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 PatientsAlmanac 2015: atrial fibrillation research in HeartEuropean Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm SocietyGenetic loci associated with heart rate variability and their effects on cardiac disease risk.Quality of care in patients with atrial fibrillation in primary care: a cross-sectional study comparing clinical and claims data.Effects of ivabradine on cardiac electrophysiology in dogs with age-related atrial fibrillationIvabradine in Cardiovascular Disease: Heart Rate Isn't Everything.Chronotropic Modulation of the Source-Sink Relationship of Sinoatrial-Atrial Impulse Conduction and Its Significance to Initiation of AF: A One-Dimensional Model Study.hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes.hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.Acute on Chronic Ivabradine Overdose: a Case Report.The Role of Ivabradine in the Management of Angina Pectoris.Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?Impact of sex and ethnicity on arrhythmic risk.Ivabradine in Management of Heart Failure: a Critical Appraisal.Ivabradine: Heart Failure and Beyond.European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.The changing circumstance of atrial fibrillation - progress towards precision medicine.Ivabradine: A Review of Labeled and Off-Label Uses.Is Heart Rate a Norepiphenomenon in Heart Failure?Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention.Ivabradine, coronary heart disease, and heart failure: time for reappraisal.European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm SocieExpert consensus document: A 'diamond' approach to personalized treatment of angina.Acute ivabradine treatment reduces heart rate without increasing atrial fibrillation inducibility irrespective of underlying vagal activity in dogs.Heart rate modulation in stable coronary artery disease without clinical heart failure: What we have already learned from SIGNIFY?Chronic Heart FailureEuropean Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm SocietThe therapeutic role of ivabradine in heart failureIvabradine Versus Beta-Blockers in Mitral Stenosis in Sinus Rhythm: An Updated Meta-Analysis of Randomized Controlled Trials
P2860
Q26741956-1206C5FB-46F4-4ACF-A732-BF4B581F4A4DQ26770598-70277EC3-EC47-40ED-A254-8EB1131ABA52Q26796261-CCB9C520-B867-4219-8F94-2DC2BDA7D814Q30313100-16328AF6-A69A-438D-931A-29AB141D8D55Q31149219-1E04896A-BBE3-4CB8-BAD1-A4928D588A1EQ35648100-0505D245-2E0B-4882-AEAC-B9C78C804A32Q35777974-0FF26E4D-6483-44F6-A89B-B784B1C3CAE3Q35851594-9912371C-CCBF-40E3-8096-09F27B497220Q35932644-630534BE-8A52-49BA-9C98-9A9F4EC092E4Q36085808-E8CE6AE6-C903-4119-A494-E54397D112ADQ36936508-BF5F3B71-D7F5-469C-BB5E-19E15408C569Q37298004-DFBFB38E-1FF9-4E05-B76E-C499708D048AQ38475657-999FBA2B-E2A1-4BDA-9A02-64717E336D93Q38508942-76AA24A1-3969-4F94-A533-0CB89C185426Q38546740-07BBA278-B769-4D81-B3CF-7D9615517D7EQ38546764-02EC854F-0C79-4899-985C-D82A46BF0804Q38571627-708D44D9-062E-486A-B18C-F2731D5DF661Q38697074-D1B348F9-DA81-4B3D-9BAA-6F5C675B9505Q38793865-245C3CB0-E6D0-49B9-8298-D0F319CFB116Q38894220-8DDD5667-B776-4953-86C9-95826511F77FQ38908301-9631744B-B4D3-4880-93B9-2355B2BD3E34Q38986970-052C29FC-A845-45FA-B867-7C961A8C0CDEQ39115969-4E724561-8156-4E15-9DBB-984EA92F96F4Q47796802-E48B7164-EF49-48CA-AF53-74E7F63F0447Q48022963-01677BC1-9D8A-4892-A82D-6F3BB3AC720FQ48227365-0EFC3526-7B0F-4E69-9733-7F9D8A350F54Q53780458-5AC58E4E-0990-41D8-8C70-DA2B85F1F9A1Q56958383-46288315-F7CE-418E-873D-FB45E5E7FAE3Q57072097-FE33CEF0-C647-46B4-A63E-7A38E3D26596Q58568726-868B7B9C-D36E-4D52-AE3D-BFE67CCB2E08Q58790420-C7B26D50-EAAE-4B3A-BEF1-ACB3E59FB2C6
P2860
Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Atrial fibrillation associated ...... randomised controlled trials.
@en
Atrial fibrillation associated ...... randomised controlled trials.
@nl
type
label
Atrial fibrillation associated ...... randomised controlled trials.
@en
Atrial fibrillation associated ...... randomised controlled trials.
@nl
prefLabel
Atrial fibrillation associated ...... randomised controlled trials.
@en
Atrial fibrillation associated ...... randomised controlled trials.
@nl
P2093
P2860
P1433
P1476
Atrial fibrillation associated ...... f randomised controlled trials
@en
P2093
Bernard D Keavney
Mauro Santibáñez Koref
Oksana Pogoryelova
Ruairidh I R Martin
P2860
P304
P356
10.1136/HEARTJNL-2014-305482
P407
P577
2014-06-20T00:00:00Z